Mykare Health Secures $1 Million Bridge Funding to Scale AI-Native Healthcare Operating System
Healthtech startup Mykare has raised an additional $1 million (₹9.4 crore)** in a bridge funding round, closing its seed funding at **$3.2 million (₹30.2 crore) . The investment came from Andrew Parker and Alfredo Vaamonde, co-founders of US-based healthtech company Papa.com, along with a Middle Eastern family office .
The fresh capital will be deployed to enhance AI capabilities, accelerate product development, and expand deeper into existing international markets across the US, UK, and the Middle East .
🔄 From Patient Aggregator to AI-Native Healthcare Operating System
Founded in 2022 by Senu Sam, Rahmatulla TM, and Joash Philipose, Mykare initially operated as a patient aggregator, connecting middle-class patients with affordable hospitals for planned, non-emergency surgeries . The startup facilitated over 14,000 surgeries, served 1 lakh+ patients, and partnered with 250+ hospitals across 12 Indian cities .
However, in October 2025, the company executed a complete business model pivot, transitioning from a B2C patient aggregator to a B2B AI-native healthcare operating system (OS) for small and mid-sized hospitals and clinics .
Why the Pivot?
Healthcare providers, especially smaller hospitals, were losing patients due to:
- Missed calls and delayed follow-ups – fragmented communication tools led to patient drop-offs.
- Disconnected systems – teams juggled 10+ tools, spending hours on administrative coordination.
- Operational inefficiencies – the focus was on managing systems rather than patient care .
“Healthcare providers should focus on patient care, not on managing missed calls, follow-ups, and disconnected systems. That’s the future we’re building at Mykare.ai.” — Senu Sam, Co-founder & CEO, Mykare
🤖 AI Agents Automating the Patient Journey
Mykare’s AI-native healthcare operating system uses agentic AI and voice AI to automate the entire patient journey—from first contact to feedback and retention .
What Mykare’s AI agents can do:
| Capability | Description |
|---|---|
| Intent Identification | Automatically identify patient needs and intent |
| Voice AI Call Handling | Answer and respond to incoming hospital calls |
| Appointment Booking | Schedule patient appointments autonomously |
| Follow-up Management | Send reminders and manage follow-ups |
| Feedback Collection | Gather patient feedback post-treatment |
| CRM Updates | Automatically update hospital CRM records |
Current Deployment & Pipeline
Mykare’s AI agents are currently deployed in 30–35 large healthcare facilities, with more than 45 clinics signed up for implementation . The startup aims to reach 100 clinics soon.
🌍 Global Expansion: India, US, UK, and Middle East
Mykare’s network now spans India, the US, the UK, and the Middle East .
| Region | Presence |
|---|---|
| India | Active in Delhi-NCR, Mumbai, Bengaluru, Hyderabad |
| USA | Tied up with a large oncology clinic chain |
| UK | Partnership with a large dental chain |
| Middle East | In talks with one of the largest dental chains in Qatar |
💡 The Bigger Picture: Healthtech’s AI Transition
Mykare’s pivot reflects a broader trend in India’s healthtech sector—moving beyond basic model-building to agentic AI, workflow automation, and specialised diagnostic copilots . The digital healthcare market in India is projected to soar from $3.8 billion in 2022 to $18.3 billion by 2030, growing at a CAGR of 21.6% .
By building an AI-native OS that automates patient acquisition, appointment booking, follow-ups, feedback, and retention, Mykare is addressing a fundamental problem: helping clinics and hospitals stop losing patients because of missed calls, delayed follow-ups, disconnected systems, and operational inefficiencies.
Summery:
🏥 Mykare Expands Hospital Partnerships with Fresh Funding
Healthtech startup Mykare will use its latest funding to grow hospital partnerships and expand planned surgery services across more Indian cities. This move strengthens its role in India’s digital healthcare ecosystem by making surgical care more accessible and organized.
💡 Why this matters:
- Hospital collaboration – partnerships improve patient access to trusted facilities.
- Surgery accessibility – expanding services ensures affordable, streamlined care for more people.
- Healthtech innovation – Mykare’s model shows how startups can bridge gaps in healthcare delivery.
- Regional expansion – scaling beyond metros brings advanced healthcare to tier-2 and tier-3 cities.
📊 Mykare’s growth reflects the broader trend of healthtech startups driving innovation in patient-centric care, while attracting investor confidence in India’s evolving medical infrastructure.
🚀 With this funding, Mykare is positioning itself as a key player in planned surgery networks, reshaping how healthcare is delivered across India.
